Jazz Pharmaceuticals plc (JAZZ) NASDAQ
226.12
-6.52(-2.80%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
226.12
-6.52(-2.80%)
Currency In USD
| Market Cap | 10.37B |
| Enterprise Value | 14.4B |
| P/E Ratio | 474.58 |
| PEG Ratio | -1.61 |
| Price/Sales Ratio | 3.2 |
| Price/Book Ratio | 3.09 |
| Enterprise/Revenue | 4 |
| Enterprise/EBITDA | 44.91 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.01 |
| Operating Margin | 0.11 |
| Return On Assets | 0 |
| Return On Equity | 0.01 |
| Revenue | 4.27B |
| Revenue/Share | 71.71 |
| Gross Profit | 3.76B |
| EBITDA | 108.46M |
| Net Income | -356.15M |
| Diluted EPS | -5.84 |
| Total Cash | 2.87B |
| Total Cash/Share | 46.43 |
| Total Debt | 5.42B |
| Total Debt/Equity | 1.2 |
| Current Ratio | 2.04 |
| Book Value Per Share | 73.22 |
| 52-Week Change | 108.81 |
| 52-Week High | 243.32 |
| 52-Week Low | 105 |
| Moving Average 50 Days | 209.72 |
| Moving Average 200 Days | 168.54 |
| Average Volume | 915,109 |
| Shares Outstanding | 62.74M |
| % Held by Institutions | 106.63 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |